georgeyann
Posted - 18 hours ago
$GSK $35 please
clan
Posted - 1 day ago
@This_Bull_Is_Retired Which partner? More parterning to come(?). $GSK $PFE $ASTRAZEN.NSE
trade_a_lot
Posted - 2 days ago
@Kbutters perhaps $GSK will buy 23andme and give Anne control?
Ismael_House
Posted - 2 days ago
$GSK $TAK LFG, expected this to move higher. Also, your thoughts on MYNZ? Who's behind the 30M share offering deal? 👀 And how could the Thermo Fisher (TMO) partnership ($210B market cap) reflect this stock movement and PR buzz everywhere on socials?
TeresaTrades
Posted - 2 days ago
Largest CALL OI decreases $ET $GSK $EQT $C $KD
HayleyMason__
Posted - 3 days ago
🚨 STOCK ALERT: MYNZ 🚨 🔥 Frankie Muniz is ALL IN—Malcolm in the Middle star & NASCAR #33 driver is now repping MYNZ! 🔎 Petra (ex-Obama advisor) dropped hints about a major U.S. lab partnership—this could be game-changing. 📈 6 news hits in 3 weeks = strong momentum. Something BIG is building here. 🌍 Already solid in the EU market, expanding with insurance-covered tests—this isn’t just hype, it’s execution. 💡 Their test has 88% accuracy, crushing competitors: EXAS (42%) & GH (20%)—clear leader in diagnostics. 💰 $1.5M private placement secured = cash on hand to scale up. 🚀 CEO teasing big plans ahead—keep an eye on this leadership. 📊 New offering deal + TMO partnership = validation and growth catalysts. ⚡ MYNZ is ticking all the boxes for a breakout! Don’t let this one fly under your radar! 💥 $GSK $TAK $ALNY
DonCorleone77
Posted - 3 days ago
$GSK GSK announces phase III trial of linerixibat met primary endpoint GSK announced headline results of GLISTEN, the ongoing global phase III clinical trial evaluating linerixibat, an investigational targeted inhibitor of the ileal bile acid transporter, IBAT, in adults with cholestatic pruritus associated with primary biliary cholangitis, a rare autoimmune liver disease. GLISTEN met its primary endpoint, with linerixibat resulting in an improvement in itch, as demonstrated by a statistically significant reduction from baseline in monthly itch score over 24 weeks versus placebo. The trial recruited PBC patients with moderate to severe itch, who were receiving stable doses of guideline-suggested therapies for pruritus, or were treatment naive, or had been previously treated. The preliminary safety results are generally consistent with those seen in prior studies of linerixibat. Further analysis of these data is ongoing. The full results of GLISTEN will be presented at a future scientific congress. Linerixibat is currently not approved anywhere in the world; it has been granted Orphan Drug Designation in both the US and EU.
foxandhounds
Posted - 3 days ago
$GSK This has been going on for over a decade. Buy low sell high on obvious very long term tramline (UK market).
Capitulation_0
Posted - 4 days ago
$CGEM Aug 19: $MRK just bought CN201, a CD19xCD3 TCE from Curon for $700M cash plus up to $600M in milestones. Curon is China bio Oct 29: $GSK to acquire CMG1A46, a clinical-stage dual CD19 and CD20-targeted T cell-engager, from Chimagen Biosciences for $300M upfront. Chimagen is China bio. $CGEM is in the lead as none of these have US IND. $AMGN, $LLY and others should be kicking tires on this.. EV $200m. What a steal.
Crash_Bash
Posted - 5 days ago
$PFE $GSK $MRNA $NVAX looool these are the guys gonna make america great again?? RFK is that you eating junk food? Seems very healthy... what a bunch of stupid people voted for these clowns to control white house
MaisieGuerrero
Posted - 6 days ago
😏🚀 MYNZ We know the date of the reverse split (RS) if there will be one, but possibly a Nasdaq extension will be granted. Last time it traded, 50 million and 19 million heavy shorts attacked. Now, it has huge credibility after the TMO partnership and the meeting. The company will decide by November 25th whether or not to do an RS based on Nasdaq's response. Anyway, after the RS, I'm not worried about what happens next. A $210 billion partner TMO signing a deal with a penny stock has never happened before. I will be loading heavy on Monday. This will go to the moon like the DRUG stock recently did. The price target (PT) is $50. The squeeze will be parabolic. $GSK $TAK
Toni19
Posted - 6 days ago
$CELG $BMY $GSK $AUPH @ThomasLD @US_Bull The good old and mysterie time in 2021! What is going on in this time?! A investigation is the right thing, when we know, what for a person our PIG is! COWEN say or see Aurinia in a bo by around $50!🤫 A investigation what is going on bevor?! Why not? We know now our PIG!😤
QuietlyAccumulating
Posted - 1 week ago
$PFE $GSK $BMY My opinion is RFK won’t get confirmed, Trump doesn’t give a crap since he tried to climb on the Harris bus first. He’s just a chess piece for Trump to negotiate other appointments.
MrNotSoNice
Posted - 1 week ago
$PFE $OGN $MRK $MRNA $GSK Pharma getting hammered on RFK (what an ass), time to buy.
MoreFlamingo
Posted - 1 week ago
$EBS $PFE $GSK Accumulate 🪱 🧠
JuggernautRaider
Posted - 1 week ago
$JFBR the reverse 13-1 split is here as was voted on in July (before I started investing). I’m still all in on Jeff’s Brands - we’re gonna help a lot of people globally.
1) buy $JFBR if you want to help fix Amazon distribution from New Jersey &UK to the Middle East
2) hold $AMZN ~ Jeff Bezos retired at the right time.
3) sell $TSLA, $NVO, $GSK ~ terrible companies that you do not want to lose money on long.
https://stocks.apple.com/ANkRVdRvGRrmdbWtkM5TZVQ
NoRisksNoFun
Posted - 1 week ago
$AUTL $gsk $PFE $BMY trash
Perkun
Posted - 1 week ago
$GSK
theflynews
Posted - 1 week ago
Deutsche downgrades GSK to Hold on Trump's RFK nomination - $GSK - https://thefly.com/permalinks/entry.php/GSKid4023128
MrNotSoNice
Posted - 1 week ago
$GSK Going long and selling puts here.
DonCorleone77
Posted - 1 week ago
$MRNA $PFE $BNTX $GSK $NVAX Trump names Robert Kennedy as Secretary of Health and Human Services President-elect Donald Trump said via Truth Social: "I am thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of Health and Human Services (HHS). For too long, Americans have been crushed by the industrial food complex and drug companies who have engaged in deception, misinformation, and disinformation when it comes to Public Health. The Safety and Health of all Americans is the most important role of any Administration, and HHS will play a big role in helping ensure that everybody will be protected from harmful chemicals, pollutants, pesticides, pharmaceutical products, and food additives that have contributed to the overwhelming Health Crisis in this Country. Mr. Kennedy will restore these Agencies to the traditions of Gold Standard Scientific Research, and beacons of Transparency, to end the Chronic Disease epidemic, and to Make America Great and Healthy Again!" Robert F. Kennedy has been skeptical of vaccines in the past. Names in the vaccine space include Moderna (MRNA), BioNTech (BNTX), Pfizer (PFE), Novavax (NVAX) and GSK (GSK).
Howlan
Posted - 1 week ago
$GSK dang, how low will it go? Worse stock ever, does this one need to get bought out and put then out of its misery?
hashtagzee
Posted - 1 week ago
$AUPH IMO Jeffries London Conference is a coverup to engage in takeover discussions with $GSK or another possible entity. They have no business stepping on Otsuka’s toes outside the US.
Fingerlickengood
Posted - 1 week ago
$CDXS $JNJ $PFE $GSK Read his Bio...this is what he does! https://www.bloomburton.com/finalist-member/stephen-dilly/
Handbiker
Posted - 1 week ago
$AUPH let's start a new rumor. Maybe it's $GSK with the mention of using both drugs at the same time..
StonkZombie
Posted - 1 week ago
$ITRM FDA’s Orange Book: Iterum has submitted patent information for four U.S. patents for ORLYNVAHTM that will be listed in FDA’s Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. Which means $GSK isn't going to swoop in next March and start competing because they won't have the rights.
